Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bruserud

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Scandinavian Journal of Immunology|March 1, 1987
Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significanceO Bruserud, G Paulsen, G Markussen, et al.
Blood|September 15, 1996
BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donorsG Pawelec, H Max, T Halder, et al.
Blood Cancer Journal|July 26, 2012
Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemiaJ Skavland, K M Jørgensen, K Hadziavdic, et al.
Leukemia & Lymphoma|August 1, 1995
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alphaG Pawelec, P Da Silva, H Max, et al.
Leukemia|November 1, 1995
Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemiaO Bruserud, B Tore Gjertsen, O T Brustugun, et al.
Leukemia|November 9, 2011
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemiaE McCormack, I Haaland, G Venås, et al.
Cell Death & Disease|March 2, 2013
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosisG Gausdal, A Wergeland, J Skavland, et al.
Leukemia|February 28, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemiaM Kontro, H Kuusanmäki, S Eldfors, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Scandinavian Journal of Immunology|March 1, 1987
Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significanceO Bruserud, G Paulsen, G Markussen, et al.
Blood|September 15, 1996
BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donorsG Pawelec, H Max, T Halder, et al.
Blood Cancer Journal|July 26, 2012
Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemiaJ Skavland, K M Jørgensen, K Hadziavdic, et al.
Leukemia & Lymphoma|August 1, 1995
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alphaG Pawelec, P Da Silva, H Max, et al.
Leukemia|November 1, 1995
Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemiaO Bruserud, B Tore Gjertsen, O T Brustugun, et al.
Leukemia|November 9, 2011
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemiaE McCormack, I Haaland, G Venås, et al.
Cell Death & Disease|March 2, 2013
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosisG Gausdal, A Wergeland, J Skavland, et al.
Leukemia|February 28, 2014
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemiaM Kontro, H Kuusanmäki, S Eldfors, et al.
Pageof 11